These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
756 related items for PubMed ID: 29916015
1. Mechanism of Splicing Regulation of Spinal Muscular Atrophy Genes. Singh RN, Singh NN. Adv Neurobiol; 2018; 20():31-61. PubMed ID: 29916015 [Abstract] [Full Text] [Related]
2. Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Singh NK, Singh NN, Androphy EJ, Singh RN. Mol Cell Biol; 2006 Feb; 26(4):1333-46. PubMed ID: 16449646 [Abstract] [Full Text] [Related]
3. Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene. Seo J, Singh NN, Ottesen EW, Sivanesan S, Shishimorova M, Singh RN. PLoS One; 2016 Feb; 11(4):e0154390. PubMed ID: 27111068 [Abstract] [Full Text] [Related]
4. Activation of a cryptic 5' splice site reverses the impact of pathogenic splice site mutations in the spinal muscular atrophy gene. Singh NN, Del Rio-Malewski JB, Luo D, Ottesen EW, Howell MD, Singh RN. Nucleic Acids Res; 2017 Dec 01; 45(21):12214-12240. PubMed ID: 28981879 [Abstract] [Full Text] [Related]
5. Evolving concepts on human SMN pre-mRNA splicing. Singh RN. RNA Biol; 2007 Dec 01; 4(1):7-10. PubMed ID: 17592254 [Abstract] [Full Text] [Related]
7. RNA in spinal muscular atrophy: therapeutic implications of targeting. Singh RN, Seo J, Singh NN. Expert Opin Ther Targets; 2020 Aug 01; 24(8):731-743. PubMed ID: 32538213 [Abstract] [Full Text] [Related]
8. Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy. Singh NN, Lee BM, DiDonato CJ, Singh RN. Future Med Chem; 2015 Aug 01; 7(13):1793-808. PubMed ID: 26381381 [Abstract] [Full Text] [Related]
9. Splicing of the Survival Motor Neuron genes and implications for treatment of SMA. Bebee TW, Gladman JT, Chandler DS. Front Biosci (Landmark Ed); 2010 Jun 01; 15(3):1191-1204. PubMed ID: 20515750 [Abstract] [Full Text] [Related]
12. Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells. Pagliarini V, Guerra M, Di Rosa V, Compagnucci C, Sette C. J Neurochem; 2020 Apr 01; 153(2):264-275. PubMed ID: 31811660 [Abstract] [Full Text] [Related]
14. Dual masking of specific negative splicing regulatory elements resulted in maximal exon 7 inclusion of SMN2 gene. Pao PW, Wee KB, Yee WC, Pramono ZA. Mol Ther; 2014 Apr 01; 22(4):854-61. PubMed ID: 24317636 [Abstract] [Full Text] [Related]
15. Advances in therapeutic development for spinal muscular atrophy. Howell MD, Singh NN, Singh RN. Future Med Chem; 2014 Jun 01; 6(9):1081-99. PubMed ID: 25068989 [Abstract] [Full Text] [Related]
16. Revealing diverse alternative splicing variants of the highly homologous SMN1 and SMN2 genes by targeted long-read sequencing. Dai M, Xu Y, Sun Y, Xiao B, Ying X, Liu Y, Jiang W, Zhang J, Liu X, Ji X. Mol Genet Genomics; 2022 Jul 01; 297(4):1039-1048. PubMed ID: 35612622 [Abstract] [Full Text] [Related]